Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GLW vs MRNA✓SelectedUSD · MRNAGLW vs MRNA performance historyLatest closeAs of-10.94%11/20
Stock and ETF performance explorer

GLW vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+267.9%
MRNA return
+786.4%
Excess return
-518.5%
Maximum drawdown
-62.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.9%-2.2%-8.8%-10.9%
7D-17.3%-12.7%-4.6%-16.9%
30D-29.9%-20.7%-9.2%-29.4%
3M-37.4%+46.3%-83.7%-38.2%
6M-47.5%+305.2%-352.7%-51.7%
YTD+8.6%+561.2%-552.6%-3.9%
1Y+21.9%+772.1%-750.2%+5.7%
3Y+252.6%+147.0%+105.7%+222.8%
5Y+183.0%-26.1%+209.0%+165.9%
All+267.9%+786.4%-518.5%+227.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling